Literature DB >> 1816112

Therapy of regional lymphadenitis following BCG vaccination.

A Baki1, M Oncü, S Usta, K Yildiz, A Karagüzel.   

Abstract

In this study we presented 92 cases with regional lymphadenitis (over 1 cm in diameter) which was caused by BCG vaccination generally performed a few days after birth. The patients were divided into four therapy groups. In group I, the lymphadenitis in 26 cases was excised totally by a surgical operation and they improved in a median period of four weeks (average: 4.4). No therapy was applied in 33 patients constituting group II and their periods of improvement were 28 weeks (average: 29.1). Sixteen cases in group III were given isoniazid (INH) 10 mg/kg for six months in addition to total surgical excision and their healing period was 4.5 weeks (average: 4). Seventeen cases in group IV were administered only INH for six months and the median improvement period was found to be 27 weeks (average: 28.2). The statistical differences in terms of the improvement periods between groups I and III, and groups II and IV were found to be insignificant (p greater than 0.05) but these differences were significant between groups I and II, groups I and IV, groups II and III, and groups III and IV (p less than 0.05). These results show that spontaneous healing is possible. Total excision is the best therapy for BCG lymphadenitis in suppurative forms and INH has no effect in shortening the therapy period.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1816112     DOI: 10.1007/BF01726452

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  Side-effects of BCG vaccination.

Authors:  G Dahlström; I Sjögren
Journal:  Bull Int Union Tuberc       Date:  1976

2.  Local complications of BCG vaccination in pre-school children and new-born babies.

Authors:  C T HSING
Journal:  Bull World Health Organ       Date:  1954       Impact factor: 9.408

Review 3.  The BCG story: lessons from the past and implications for the future.

Authors:  P E Fine
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr

4.  Suppurative lymphadenitis in newborn babies after change of BCG vaccine.

Authors:  P Hengster; M Fille; G Menardi
Journal:  Lancet       Date:  1991-05-11       Impact factor: 79.321

5.  Does BCG vaccination protect the newborn and young infants?

Authors:  H G ten Dam; K L Hitze
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

6.  Protective efficacy of neonatal Bacillus Calmette-Guérin vaccination against tuberculosis.

Authors:  S Sirinavin; T Chotpitayasunondh; S Suwanjutha; P Sunakorn; T Chantarojanasiri
Journal:  Pediatr Infect Dis J       Date:  1991-05       Impact factor: 2.129

7.  [Adenitis following BCG vaccination].

Authors:  I Claiciu; R Bărbulescu; E Popescu; L Poeniţä; E Iliescu
Journal:  Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol       Date:  1975 Apr-Jun

8.  [BCG vaccination of the newborn infant with the 131 Copenhagen strain].

Authors:  U Stephan; H Haupt; R Scheier; A Nada; U Grimrath; H G Schmitt
Journal:  Klin Padiatr       Date:  1986 Jul-Aug       Impact factor: 1.349

9.  Disseminated tuberculoid lesions in infants following BCG vaccination.

Authors:  C L Trevenen; R D Pagtakhan
Journal:  Can Med Assoc J       Date:  1982-09-15       Impact factor: 8.262

10.  Significance of the number of viable units in BCG vaccines.

Authors:  G Nyerges; M Drinóczy
Journal:  Dev Biol Stand       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.